Transcript Name of Company - Missouri Tech Expo

Paul Whiteside, M.S., C.E.O.
Email: [email protected]
Alt.: [email protected]
Systematic Problems




“Point-and-shoot”
paradigm
Easy to misuse
Inefficient procedures
No training required
NPO’s:



64% of litigations ‘04-’12
100% of litigations in 2012
Mean indemnity payment
is $380k1,2
Waveguides:





Light transmitted directly into skin
No reflections
Easier to use
Anticipated to be more effective
Modular
Stakeholder opinions:



Need to prevent accidental firing
Ergonomics are important
Efficiency is key
Market dynamics:




Total U.S. Market: $800M
$46M for consumables alone
CAGR: 12% (Frost & Sullivan)
R&D performed by Start-Ups
Annual procedures: (clinics only)



33,363 tattoo removals
1,080,082 hair removal procedures
439,493 skin resurfacings
Medical Spas make up another 30-60% of
the market3
Medical Photonics Industries:

Keurig-style business model

“Cheap” hand-pieces
 Frequently purchased consumables


FDA 510(k)
Acquisition or partnership
Market Leaders:




Syneron Medical: 14 acq, 7 pt, 2 lic
Cynosure: 4 acq, 4 dist
Palomar: 9 pt, 3 lic
Lumenis
Intellectual Property:


Patent pending through OTMIR (#13UMC079prov)
Additional patent disclosures filed
FDA 510(k):

Show functional similarity to FDA approved laser devices

Hoya ConBio RevLite (K) 103118
 SideLaze800 Laser Beam Accessory (K) 121127
Paul Whiteside
Eric Barmann
Medical Photonics
CEO
Medical Photonics
CFO
M.S., Ph.D. Student
Principal Inventor
B.S., M.B.A.
I.P. expert
John Viator, Ph.D.
Nicholas Golda, M.D.
Michael Flagg, PMP
Advisory Board
Advisory Board
Advisory Board
Program Director
Biomedical Engineering
Duquesne University
Medical Director
Dermatology and Skin Surgery
Center, University of Missouri
FDA Regulatory Expert,
MU Research Reactor
Efficiency
Improvement
(I.P. #2)
2014
Q2 2015
Coulter Seed Funding:
Low-energy waveguide
development
Coulter Seed Funding
In vitro
Pig Skin Testing
Q3 2015
Waveguide
Fabrication
Optimization
Prototype
Fabrication
Q4 2015
Q1 2016
SBIR
Application
Fast Track Funding (MU system grant)
Preclinical Trials
Q2 2016
Expected SBIR
Decision
2017
2018
Clinical Trials to
follow in SBIR
Phase II
SBIR Phase I, Phase II,
Coulter, MTC
Paul Whiteside, M.S., C.E.O.
Email: [email protected]
Alt.: [email protected]
Image 1: www.thetattooeditor.com/laser-tattoo-removal-technique/
Image 2: www.deccanchronicle.com/140702/nation-current-affairs/article/most-indian-laser-clinics-do-notfollow-any-norms
1. H. Ray Jalian, “Increased Risk of Litigation Associated with Laser Surgery by Nonphysician Operators”, JAMA
Dermatol. 150(4), 2014
2. H. Ray Jalian, “Common Causes of Injury and Legal Action in Laser Surgery”, JAMA Dermatol., 149(2), 2013
3. Cosmetic Surgery National Data Bank, Statistics 2014 www.surgery.org/sites/default/files/2014-Stats.pdf